Ulcerative colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with ulcerative colitis Patient is in clinical remission, FIT negative (hemoglobin level in stool <50 ng/mL) Patients are scheduled to reduce the dosage of one drug. Patients who are able to obtain written consent for participation in this study after receiving a thorough explanation of the study and after fully understanding the study. Outpatients
Exclusion criteria
Exclusion criteria: Difficulty in performing the fecal immunochemical test at home. Patients who are deemed inappropriate as research subjects by the principal investigator and research coordinator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Relapse rate that required a stronger level of treatment than before the drug reduction | — |
Countries
Japan
Contacts
Okayama University Department of Gastroenterology